Growth Metrics

Neogenomics (NEO) Non-Current Debt: 2013-2020

Historic Non-Current Debt for Neogenomics (NEO) over the last 4 years, with Mar 2020 value amounting to $90.6 million.

  • Neogenomics' Non-Current Debt rose 5.36% to $90.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $90.6 million, marking a year-over-year increase of 5.36%. This contributed to the annual value of $91.8 million for FY2019, which is 4.49% up from last year.
  • Latest data reveals that Neogenomics reported Non-Current Debt of $90.6 million as of Q1 2020, which was down 1.33% from $91.8 million recorded in Q4 2019.
  • Neogenomics' Non-Current Debt's 5-year high stood at $94.2 million during Q2 2019, with a 5-year trough of $52.2 million in Q3 2016.
  • Its 3-year average for Non-Current Debt is $87.8 million, with a median of $90.6 million in 2020.
  • Its Non-Current Debt has fluctuated over the past 5 years, first spiked by 34.25% in 2016, then dropped by 5.99% in 2018.
  • Neogenomics' Non-Current Debt (Quarterly) stood at $70.1 million in 2016, then decreased by 5.04% to $66.6 million in 2017, then skyrocketed by 31.92% to $87.9 million in 2018, then climbed by 4.49% to $91.8 million in 2019, then grew by 5.36% to $90.6 million in 2020.
  • Its Non-Current Debt stands at $90.6 million for Q1 2020, versus $91.8 million for Q4 2019 and $93.0 million for Q3 2019.